ABSTRACT
Methicillin Resistant Staphylococcus Aureus (MRSA) has gained much attention in the last decade, as the MRSA is a major cause of hospital acquired (nosoconical infections). β-lactam antibiotics are the preferred drugs against S. aureus infections, although S. aureus has developed resistance to the β-lactam antibiotics due to the production of chromosomal or plasmid mediated β-lactamases or by producing Pencillin Binding Proteins (PBPs). The Extended Spectrum β-Lactamase (ESBL) producers are highly resistant to several conventional antibiotics. This limits therapeutic options. Hence efforts are now taken to screen few medicinal plants, which are both economic and less toxic, against the ESBL producers. Among the several plants screened, we have chosen to screen the alcohol extracts of a traditional medicinal plant, Elephantopus scaber (Asteraceae) against several clinical strains of ESBL producing MRSA. ESBL producers were screened by double disc synergy test. Methanol, hexane and acetone extracts of Elephantopus scaber were investigated for their ability to inhibit the growth of the chosen ESBL producing multidrug-resistant bacteria by the disc diffusion method. Minimal Inhibitory Concentrations (MICs) were determined by micro broth dilution method. Synergistic interaction of plant extracts with certain antibiotics was also evaluated. On the basis of promising activity, acetone extracts were fractionated and their phytochemical analysis showed the presence of terpenoids, proteins and traces of steroids. TLC bioautography of the fraction showed the active compound to be terpenoids. The strong in vitro antibacterial activity of terpenoid derivatives against ES βL-producing MRSA bacteria suggests the compounds might find wide pharmaceutical use. Further investigations to elucidate the active compound are required.
PDF Abstract XML References Citation
How to cite this article
DOI: 10.3923/ijp.2007.165.169
URL: https://scialert.net/abstract/?doi=ijp.2007.165.169
INTRODUCTION
Infectious diseases, the leading cause of premature deaths, in the world are killing most 50,000 people every day. An increase in antibiotic resistant bacteria is threatening world population with the recurrence of infectious diseases (e.g., Tuberculosis and cholera) that were once thought to be under control at least in developed countries. In the recent years incidence of multi-drug resistance in Gram positive (S. aureus S. pneumoniae), Gram negative (E. coli, Shigella, Haemophilus influenzae) and other bacteria like Mycobacterium tuberculosis has been reported from all over the world (Mulligen et al., 1993; Sajduda et al., 1998; Sanches et al., 1998). These multi-drug resistant bacteria have also created additional problems in cancer and AIDS patients. Methicillin Resistant Staphylococcus aureus (MRSA) has gained much attention in the last decade, as the MRSA is a major cause of hospital acquired (nosocomial) infections. β-lactam antibiotics are the preferred drugs against S. aureus infections, although, S. aureus has developed resistance to the β-lactam antibiotics due to the production of chromosomal or plasmid mediated β-lactamases or by producing Pencillin Binding Proteins (PBPs). All the S. aureus strains have four PBPs (PBP1 to PBP4), but MRSA express a special PBP (PBP2 or PBP2a) from the mecA gene. PBP2 a takes over the biosynthetic function of normal PBPs in the presence of inhibitory concentration of β-lactams because PBP2 has a decreased binding affinity to β-lactams (Bachi and Rohrer, 2002). This has resulted in the development of multidrug resistance against β-lactam and other antibiotics. Moreover, increased incidence of vancomycin-resistant MRSA has also been reported (Hiramatsu et al., 1997). Thus, the number of effective exogenous antibiotics is decreasing, therefore concerted efforts are to be made to identify antimicrobial materials from natural products and traditional medicines.
Antimicrobial activity of medicinal plants against drug-resistant bacteria, including MRSA and their interaction with β-lactam antibiotics/Beta-lactamase activity on mec gene product have been reported in one or the other plants, including Camellia sinensis, Rosa canina, Scutellaria amoena and Arctostaphylos uvaursi, from different parts of the world (Yam at el., 1998; Shioto et al., 2000; Liu et al., 2000; Shimuzu et al., 2001; Palombo and Semple, 2002). Such activities mainly in traditionally used Indian medicinal plants are less explored. India is fortunate in possessing the worlds richest flora with about 120 families of plants, comprising of 1,30,000 species. The use of about 2400 of these plants have been mentioned in Ayurvedic and Unani texts and tribals use many others. Various preparations of these medicinal plants are used in treating ailments such as wounds skin diseases, dysentery, cough, cold, jaundice and leprosy etc (Chaudhary, 1996).
Screening of Indian medicinal plants revealed varying degree of antimicrobial activity against various pathogenic and opportunistic microorganisms (Ahmad et al., 1998; Mehmood et al., 1999; Ahmad and Beg, 2001). It is therefore, expected that such bioactive plant extracts may provide some alternative compounds to be used against MRSA with or without the combination of β-lactam antibiotics. In search of such an activity, crude alcoholic extracts and fractions of some Indian medicinal plants were evaluated for their antibacterial activity against β-lactamase producing- methicillin resistant S. aureus isolates and an isolate of methicillin sensitive S. aureus (MSSA). Preliminary data on the interaction between active plant extracts and certain antibiotics has also been generated.
MATERIALS AND METHODS
Antibiotic resistance profile of test strains: Urine samples of UTI infected patients from CSI Mission General hospital, Tiruchirappalli, India were processed. Ninety six strains of MRSA and a 127 strains of methicillin sensitive S. aureus (MSSA) were obtained during a period of 6 months (June 2005-December 2005). These strains were tested for their antibiotic sensitivity by disk diffusion method (Bauer et al., 1966). Antibiotic discs/powders were purchased from Hi-Media Lab. Ltd, Mumbai (India).
Plant material: Elephantopus scaber Linn. is a small herb, which grows in the wild throughout the tropical regions of the world. The major phytochemical constituents of the plant are elephantopin, triterpenes, stigmasterol, epofriedelinol and lupeol (Rastogi and Mehrotra, 1990; Kritikar and Basu, 1991). The plant has been used in the Indian system of medicine as analgesic, diuretic, astringent and antiemetic. The leaves of the plant were known to be used for bronchitis, small pox and diarrhea and as a brain tonic (Sankar et al., 2001). Recently, it has been shown to possess anti-inflammatory and antitumour activity in animal models (Reico, 1989) and also found to have antibacterial activity against a few standard bacterial strains.
Plant extract preparation: The plant used in this study, Elephantopus scaber was obtained commercially and identified and voucher specimen was deposited at the Botany department of the College. The plants were shade dried and powdered. Air-dried powder (1 kg) was extracted with 2 L of acetone in a Soxhlet apparatus for 18 h. After filtration of the extract, it was evaporated at 30°C until dryness. The obtained crude extract (56 g L-1) was chromatographed on a silica gel column. Initial elution with discontinuous gradient of ethyl acetate and hexane, then with acetone and ethyl acetate, with acetone and chloroform and finally with chloroform and hexane. This yielded 17 fractions (F1-17). The fractions F1-5, F6-8, F9-11, F12-15 and F16-17 were combined according to their Rf values into five fractions finally.
Screening for ESBL production: The antibiogram obtained for the isolated bacteria revealed them to be multi-drug resistant clinical isolates. The tested isolates were screened for ESBL production following double disc synergy test (Miles and Amyes, 1996). ESBL presence was assayed using the following antibiotic discs: Cefotaxime (30 μg), Cefotaxime/clavulanic acid (30/10 μg), ceftazimide (30 μg) and ceftazidime/clavulanic acid (30/10 μg) E. coli ATCC 35218 and E. coli ATCC 25922 served as positive and negative controls, respectively.
Antibacterial activity: The antibacterial activity of the extract was evaluated by the disc diffusion method (Bauer et al., 1966). Mueller Hinton agar plates were prepared and inoculated on the surface with the test organism whose concentration was adjusted using 0.5 std. McFarlands opacity tube (McFarland, 1907). About 10 μL of the test extracts (1 g in 10 mL DMSO) were impregnated on sterile discs (Himedia, Mumbai, India) and on drying; the discs were placed on Mueller Hinton plates. After incubation for 24 h at 37°C, positive results were established by the presence of clear zones of inhibition around the active extracts. Also DMSO and solvent only discs were used as controls. The assessment of the antibacterial activity was based on the measurement of diameter of the zone of inhibition formed around the standard antibiotic discs (NCCLS, 2002).
Determination of minimal inhibitory concentration and Minimal bactericidal concentration: Minimal Inhibitory Concentration (MIC) and Minimal Bactericidal Concentration (MBC) were determined for the extracts by broth dilution method as described by Ayafor et al. (1994). The concentration at which there was no visually detectable bacterial growth was taken as the MIC and the concentration at which there was no bacterial growth after inoculation in Mueller Hinton agar was taken as MBC.
Synergistic interaction of plant extracts with antibiotics: Synergistic interaction between antibiotics like ampicillin, tetracycline and chloramphenicol with crude plant extracts was studied by agar well diffusion method. For determining the synergistic effects of plant extracts with antibiotic, the wells were punched at a predetermined distances so that their inhibitory circles touch each other only tangentially without influencing each other as recommended by Chattopadhay et al. (1988). The wells were inoculated with plant extract and antibiotic separately. Plates were then incubated at 37°C, for 18 h. Enlargement of inhibition zones indicates a positive interaction (synergism).
Phytochemical analysis of plant extracts: Major phytocompounds, in the crude extracts of plants, were detected by standard colour tests and thin layer chromatography, as described elsewhere (Wagner and Bladt, 1995; Ahmad and Beg, 2001).
TLC bioautography: For direct bioautographic assay, agar overlay assay (Slusarenko et al., 1989) was used, with little modification, to detect antimicrobial compounds in plant extracts active against MRSA. Five to ten microliter of each plant extract, was spotted on preparative E-MERCK chromatographic Silica gel f 254 thickness 0.25 mm plates of 3x8 cm. Only one solvent system (acetone: ethanol: 1:1) was used. One milliliter of 106 CFU mL-1 broth culture was used for every 10 mL of nutrient agar. Developed chromatograms were placed in autoclave petri plates. Culture was added to the melted nutrient agar medium and a thin layer was poured over the chromatograms. Plates were incubated at 37°C, for 24 h. Zones of inhibition of bacterial growth could be seen around the active chromatogram spot. The spot was also confirmed by flooding the plates with 0.02 mg mL-1 solution of p-iodonitro-tetzolium violet.
RESULTS
Antibiotic sensitivity of Methicillin Resistant Staphylococcus aureus (MRSA) strains showed resistance to multi-drugs, while methicillin sensitive S. aureus (MSSA) strains were sensitive to all antibiotics tested.
Table 1: | Minimal inhibitory concentrations of the different extracts of E. scaber against MRSA and MSSA |
![]() |
Table 2: | Minimal inhibitory concentrations of the different fractions of the acetone extract of E. scaber against MRSA and MSSA |
![]() |
The Minimum Inhibitory Concentration (MIC) of β-lactam antibiotics (benzyl penicillin, ampicillin, cloxacillin, cefixime) ranged from 250 to>2000 μg mL-1 against the strains of methicillin resistant Staphylococcus aureus while the MIC values of these antibiotics against the MSSA strain ranged from 6.25 to 25 μg mL-1. Production of β-lactamases was a common characteristic for these MRSA and MSSA srains. The extract of the traditionally used Indian medicinal plant was tested against the above mentioned clinical strains of β-lactamase producing MRSA and MSSA. The extract of Elephantopus scaber showed little activity against MRSA strains, compared to the MSSA strains. The antibacterial potency of the crude plant extracts was determined in term of Minimum Inhibitory Concentration (MIC) against S. aureus strains. MIC of the plant extracts ranged from 3.12 to 50 mg mL-1 against the MRSA strains (Table 1). On the basis of the promising activity, the acetone extract of Elephantopus scaber were fractioned in a silica gel column. Antimicrobial activity was located in 4 acetone fractions among the nine obtained. Phytochemical analysis showed the presence of alkaloids, phenols, glycosides, tannins, saponins, steroids and terpenoids (Table 2). TLC-bioautography of the plant extracts revealed terpenoids as the major bioactive phytoconstituents.
DISCUSSION
The choice of drugs, to be used against MRSA, is shrinking day by day as susceptibility of MRSA to drugs is decreasing by target site alteration, enzyme modification and permeability changes (Brumfitt and Hamiltton-Miller, 1989). Different substrate specificity/spectrum has been reported in various type of MRSA strains, like β-lactamase positive and PBP2, inducible β-lactamase negative and PBP2 constitutive, chromosomal and plasmid-encoded β-lactamases, production of β-lactamases may also directly influence the resistance level in these strains since these strains are resistant to methicillin where PBP2 is expected to play major role in the development of resistance against not only with β-lactam antibiotics but also to unrelated antibiotics. The β-lactamase produced by MRSA also hydrolyzed methicillin. These strains were resistant to β-lactam antibiotics with high MIC values, including methicillin (>100 μg mL-1). Therefore, it is expected that this clinical strain might belong to MRSA group and not to BORSA/MODSA group which confers low level of resistance against methicillin. To confirm the presence of mecA gene in this strain, further characterization is needed. In the present study, the zones of inhibition was recorded in the range of 11 mm to 27 mm at 100 μg mL-1 concentration. The antibacterial potency of the fractions of the acetone extract was determined in terms of MIC, which ranged from 125-1000 μg mL-1. The behavior of S. aureus strains, against individual plant extract differed significantly, which requires further investigations in terms of their active constituents and its effect on the MRSA strains. Fractionations of the plant extracts revealed that the acetone fractions showed good activity while less activity was found in the methanol and hexane fractions. Our findings are in agreement with the reports on other plants (Yam et al., 1998; Palombo and Semple, 2002). However, this is probably the first report on the chosen Indian medicinal plants against β-lactamase producing MRSA and MSSA strains from Tamil Nadu, South India. The interaction of the plant extracts with tetracycline showed synergistic interaction, while the extract exhibited less synergism with Tc as well as with β-lactam antibiotic (ampicillin). The possible mechanism for such an interaction might be exploited in combination chemotherapy but requires in-depth understanding. Present study is in agreement with few others (Iinuma et al., 1996; Lee et al., 1998) who have also demonstrated positive interaction of certain plant extracts with antibiotics.
Phytochemical analysis by color test and TLC bioautography of certain extracts revealed the presence of terpenoids, phenols, steroids, glycosides, saponins as major phytoconstituents. To identify the exact chemical nature of active compounds in these plant extracts detailed phytochemical investigations are needed. Therefore, activity based fractionations of these extracts and determination of active principle and its mechanism of interaction with antibiotics have to be explored in order to uncover the real therapeutic potential of these extracts in the management of infectious diseases caused by MRSA strains and probably by other multidrug resistant bacteria.
REFERENCES
- Aarbakke, J., G. Janka-Schaub and G.B. Elion, 1997. Thiopurine biology and pharmacology. Trends Pharmacol. Sci., 18: 3-7.
CrossRefDirect Link - Bostrom, B. and G. Erdmann, 1993. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Am. J. Pediatr. Hematol. Oncol., 15: 80-86.
Direct Link - Evans, W.E., M.V. Relling, J.H. Rodman, W.R. Crom, J.M. Boyett and C.H. Pui, 1998. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N. Engl. J. Med., 338: 499-505.
Direct Link - Ma, X.L., Y.M. Hu, M.Y. Wu and X.S. Cui, 2000. Concentration of three metabolites of 6-MP in red blood cell by RP-HPLC. Chin. J. Pharm. Anal., 20: 296-299.
Direct Link - Rostami-Hodjegan, A., L. Lennard and J.S. Lilleyman, 1995. The accumulation of mercaptopurine metabolites in age fractionated red blood cells. Br. J. Clin. Pharmacol., 40: 217-222.
Direct Link - Schmiegelow, K. and I. Bruunshuus, 1990. 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia and its relation to leukopenia. Cancer Chemother. Pharmacol., 26: 288-292.
CrossRef - Ahmad, I., Z. Mehmood and F. Mohammad, 1998. Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol., 62: 183-193.
CrossRefPubMedDirect Link - Ahmad, I. and A.Z. Beg, 2001. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J. Ethnopharmacol., 74: 113-123.
CrossRefDirect Link - Ayafor, J.F., M.H.K. Tchuendem, B. Nyasse, F. Tillequin and H. Anke, 1994. Novel bioactive diterpenoids from Aframomum aulacocarpos. J. Nat. Prod., 57: 917-923.
CrossRefPubMedDirect Link - Berger-Bachi, B. and S. Rohrer, 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol., 178: 165-171.
CrossRefPubMedDirect Link - Brumfitt, W. and J. Hamilton-Miller, 1989. Methicillin-resistant Staphylococcus aureus. N. Engl. J. Med., 320: 1188-1196.
CrossRefPubMedDirect Link - Hiramatsu, K., H. Hanaki, T. Ito, K. Yabuta, T. Ogura and F.C. Tenova, 1997. Methicillin resistant Staphylococcus aureus clinical strains with reduced vancomycin susceptibility. J. Anti-Microbial Chemother., 41: 135-146.
Direct Link - Iinuma, M., H. Tosa, T. Tanaka, F. Asai, Y. Kobayashi, R. Shimano and K.I. Miyauchi, 1996. Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol., 48: 861-865.
Direct Link - Lee, C.K., H. Kim, K.H. Moon and K.H. Shin, 1998. Screening and isolation of antibiotic resistance inhibitors from herb materials-resistance inhibition of volatile components of Korean aromatic herbs. Arch. Pharm. Res., 21: 62-66.
PubMed - Liu, I.X., D.G. Durham and R.M.E. Richards, 2000. Baicalin synergy with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other β-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol., 52: 361-366.
Direct Link - McFarland, J., 1907. The nephelometer: An instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. J. Am. Med. Assoc., 49: 1176-1178.
CrossRefDirect Link - Mehmood, Z., I. Ahmad, F. Mohammad and S. Ahmad, 1999. Indian medicinal plants: A potential source for anticandidal drugs. Pharmaceut. Biol., 37: 237-242.
CrossRefDirect Link - Mulligan, M.E., K.A. Murray-Leisure, B.S. Ribner, H.C. Standiford and J.F. John et al., 1993. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management. Am. J. Med., 94: 313-328.
CrossRefPubMedDirect Link - Palombo, E.A. and S.J. Semple, 2002. Antibacterial activity of plant extracts against Methicillin Resistant Staphylococcus Aureus (MRSA) and Vancomycin Resistant Enterococci (VRE). J. Basic Microbiol., 42: 444-448.
Direct Link - Redo, M.C., J.L. Rios and A. Villar, 1989. A review of some antimicrobial compounds isolated from medicinal plants reported in the literature 1978-1988. Phytother. Res., 3: 117-125.
CrossRefDirect Link - Sankar, V., R. Kalirajan, F. Sweetlin Vivian Sales and S. Raghuraman, 2001. Anti inflammatory activity of Elephantopus scaber in albino rats. Indian J. Pharm. Sci., 63: 523-525.
Direct Link - Sajduda, A., J. Dziadek, A. Dela, N. Zalewskaschonthaler, Z. Zwalska and J.M.C. Fadden, 1998. DNA finger printing as an indicator of active transmission of multi-drug resistant tuberculosis in poland. Int. J. Infec. Dis., 3: 12-17.
Direct Link - Sanches, I.S., Z.C. Saraiva, T.C. Tendeir, J.M. Serra, D.C. Dias and H. Delencastre, 1998. Extensive intra-hospital spread of methicillin resistant Staphyloccocal clone. Int. J. Infect. Dis., 3: 26-31.
Direct Link - Shimuzu, M., S. Shiota, T. Mizushima, H. Ito, T. Hatano, T. Yoshida and T. Tsuchiya, 2001. Marked petentiation of activity of β-lactams against methicillin resistant Staphylococcus aureus by corilagin. Antimicrob. Agents Chemother., 45: 3198-3201.
Direct Link - Shiota, S., M. Shimizu, T. Mizushima, H. Ito, T. Hatano, T. Yoshida and T. Tsuchiya, 2000. Restoration of effectiveness of β-lactams on methicillin resistant Staphylococcus aureus by Tallimagrandini from rose red. Fems Microbial. Lett., 185: 135-138.
Direct Link - Yam, T.S., J.M.T. Hamilton-Miller and S. Shah, 1998. The effect of a component of tea camellia sinensis on methicillin resistance, pbp2 synthesis and β-lactamase production in S. aureus. J. Antimicrob. Chemother., 42: 211-216.
Direct Link